National Heart, Lung, and Blood Institute; Notice of Meeting, 23475 [2018-10679]
Download as PDF
<![CDATA[
23475
Federal Register / Vol. 83, No. 98 / Monday, May 21, 2018 / Notices
Dated: May 15, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2018–10679 Filed 5–18–18; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Meeting
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NHLBI.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Heart, Lung, And Blood
Institute, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, NHLBI.
Date: June 11, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 6th Floor, Room 6S233, 10
Center Drive, Bethesda, MD 20892.
Contact Person: Robert S. Balaban, Ph.D.,
Scientific Director, Division of Intramural
Research National Institutes of Health,
NHLBI Building 10, 4th Floor, Room 1581, 10
Center Drive, Bethesda, MD 20892, 301–496–
2116, balabanr@nhlbi.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/node/80103, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Division of State
Programs—Management Reporting
Tool (DSP–MRT) (OMB No. 0930–
0354)—Revision
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Substance Abuse
Prevention (CSAP) aims to monitor
several substance abuse prevention
programs through the DSP–MRT, which
reports data using the Strategic
Prevention Framework (SPF). Programs
monitored through the DSP–MRT
include: SPF-Partnerships for Success,
SPF- Prescription Drugs, Prescription
Drug Overdose, and First ResponderComprehensive Addiction and Recovery
Act. This request for data collection
includes a revision from a previously
approved OMB instrument.
Monitoring data using the SPF model
will allow SAMHSA’s project officers to
systematically collect data to monitor
their grant program. In addition to
assessing activities related to the SPF
steps, the performance monitoring
instruments covered in this statement
collect data to assess the following
grantee required specific performance
measures:
• Number of training and technical
assistance activities per funded
community provided by the grantee to
support communities
• Number of training and technical
assistance activities (numbers served)
provided by the grantee
• Number of subrecipient communities
that improved on one or more targeted
National Outcome Measures
• Number of grantees who integrate
Prescription Drug Monitoring Program
(PDMP) data into their program needs
assessment
• Number of naloxone toolkits
distributed
Changes to this package include the
following:
• Inclusion of Intervention names in the
standard tool
• Inclusion of Community outcomes
reporting
• Inclusion of questions on training
services requested and referrals/
receiving treatment services in the
PDO/FR–CARA supplemental section
ANNUALIZED DATA COLLECTION BURDEN
Number of
respondents
sradovich on DSK3GMQ082PROD with NOTICES
Instrument
Responses
per
respondent
Total
number of
responses
Hours per
response
Total burden
hours
Standard DSP Monitoring Tool ............................................
Section A: Rx .......................................................................
Section B: PDO/FR CARA ...................................................
Section C: PFS ....................................................................
117
25
23
71
4
2
4
1
468
63
100
71
3
1
1
3
1,404
42
100
213
FY2020 Total ................................................................
117
........................
702
........................
1,759
VerDate Sep<11>2014
18:58 May 18, 2018
Jkt 244001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
E:\FR\FM\21MYN1.SGM
21MYN1
]]>Agencies
[Federal Register Volume 83, Number 98 (Monday, May 21, 2018)]
[Notices]
[Page 23475]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10679]
[[Page 23475]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, NHLBI.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Heart, Lung, And Blood Institute, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NHLBI.
Date: June 11, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 10, 6th Floor,
Room 6S233, 10 Center Drive, Bethesda, MD 20892.
Contact Person: Robert S. Balaban, Ph.D., Scientific Director,
Division of Intramural Research National Institutes of Health, NHLBI
Building 10, 4th Floor, Room 1581, 10 Center Drive, Bethesda, MD
20892, 301-496-2116, [email protected].
Information is also available on the Institute's/Center's home
page: https://www.nhlbi.nih.gov/node/80103, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: May 15, 2018.
Michelle D. Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-10679 Filed 5-18-18; 8:45 am]
BILLING CODE 4140-01-P
